Search results

Selected filters:

Non-Practising Entities
Europe

Article type

Topic

Sector

Jurisdictions

82 results found for your search

Sort options
10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

03 June 2019

Infineon significantly bolsters its patent portfolio with Cypress acquisition  

Consolidation in the chip industry continues as the deal brings together two players with plenty of experience in the secondary market

09 April 2019

'Reverse patent trolls' plague big pharma in China

The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals

01 April 2019

IP-related statistics from the recent past

A selection of recently reported facts and figures.

07 March 2019

Lone inventor takes on Huawei in case that exposes the deep disparities in the US patent system

Portuguese national says he has sold his house to hire an attorney to go after the Chinese company over alleged IP theft – a huge leap of faith given US assertion realities

06 March 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy 

26 February 2019

SEP licence with Sisvel creates template for deal that could end up saving industry billions of dollars, says RPX CEO 

Dan McCurdy (left) and Mattia Fogliacco (right) open up about the ground-breaking patent agreement their two firms secured in January - and explain why it is potentially so important

28 January 2019

Critical condition: has Section 101 put the US medical device sector on life support?

As fears grow over subject-matter eligibility and technological convergence threatens to reshape the competitive landscape, patent strategy has become even more crucial for medical device companies

10 January 2019

Sisvel and RPX ink major Wi-Fi SEP licensing deal

Agreement covers a total of 700 patents and is a big win for the CEOs of both firms - Mattia Fogliacco (left) and Dan McCurdy (right)

04 January 2019

All the major China IP stories you missed over the holidays

Retrial ordered in Huawei v InterDigital; Apple representatives threatened with detention in continuing injunction flap; national IP appeals court opens doors and much more from the Middle Kingdom

14 December 2018

Huge portfolio of Nokia assets about to hit the market in test for investor appetite for IP

“Largest open market patent deal in telecoms since Nortel” will reveal extent of secondary market’s slow recovery

30 November 2018

How a Chinese court would have decided the <em>Unwired Planet</em> appeal

Previous FRAND-related rulings indicate judges in China could set a global rate, would adopt the hard-edged non-discrimination obligation and would consider the parties' negotiation behaviours when reaching their decisions 

30 November 2018

Time is running out to nominate the world’s leading IP strategists

There is not much time left to make nominations for the 2019 edition of IAM Strategy 300, our exclusive guide on the world's best IP strategists.

29 November 2018

OPINION: It's time to sort out the connected car disconnect

TCL v Ericsson and Unwired Planet v Huawei send two very different messages to auto companies being approached by patent pools such as Avanci to take SEP licences, says Unified Patents' chief IP counsel Jonathan Stroud 

23 November 2018

Xiaomi inks video licence as Huawei loses German court case

Sources tell IAM MPEG-LA has secured an AVC/H.264 licence with Xiaomi.